DISASTER MEDICINE No.2 •2023

https://doi.org/10.33266/2070-1004-2023-2

Review article

Prospects of N-Acetylcysteine Use as a Nephroprotector in Patients with Concomitant Trauma and other Pharmacological Aspects of Clinical Use of this Substance

Miziev I.A. 1, Makhov M.Kh. 1, Gubzhokova A.B. 1, Kardanov A.A. 1, Kardanova L.D. 1

Download the article in pdf format

1 Kabardino-Balkarian State University named after H.M. Berbekov, Nal’chik, Russian Federation

UDC 615.03:616-001

Pp. 45–50

Summary. Objectives of the study were to analyze a wide range of published data; to study biological activity and bioavailability of N-acetylcysteine (N-AC) as well as a possibility of using the drug in clinical practice to eliminate oxidative stress and inflammatory reactions in pathological conditions and nosologies; to study its therapeutic effectiveness in renal dysfunction in patients with concomitant trauma.

Study materials and methods. Materials of research: scientific publications on the specified problems. Research method: analytical.

Results of the study and their analysis. A review of domestic and foreign literature on the role of N-acetylcysteine in correction of oxidative stress and protection against free radicals is presented. The great role of N-acetylcysteine for the replenishment of the intracellular content of glutathione, the main cellular antioxidant, as well as the potential possibility of using N-acetylcysteine in clinical practice for various pathologies and diseases is investigated. Review of the results of a large number of studies leads the authors to the conclusion that this pharmacological substance is a very promising means for replenishing the intracellular content of glutathione and can be used in the treatment of a number of diseases.

Keywords: clinical use, glutathione system, N-acetylcysteine, nephroprotective therapy, oxidative stress, patients with concomitant trauma, pharmacological aspects

Conflict of interest. The authors declare no conflict of interest

For citation: Miziev I.A., Makhov M.Kh., Gubzhokova A.B., Kardanov A.A., Kardanova L.D. Prospects of N-Acetylcysteine Use as a Nephroprotector in Patients with Concomitant Trauma and other Pharmacological Aspects of Clinical Use of this Substance. Meditsina Katastrof = Disaster Medicine. 2023;2:45-50 (In Russ.). https://doi.org/10.33266/2070-1004-2023-2-45-50

 

REFERENCES

  1. Miziyev I.A., Makhov M.Kh. Investigation of Serum Cysteine Concentration to Monitor Glomerular Filtration Rate for Early Diagnosis of Acute Kidney Injury in Patients with Combined Trauma. Urologiya = Urology. 2017;5:48-51 (In Russ.).
  2. Miziyev I.A., Makhov M.Kh. Diagnosis of Acute Kidney Injury in the Early Stages of Treatment of Patients with Concomitant Trauma Using a High-Precision Biomarker of Cystatin C. Perspektivnyye Innovatsionnyye Proyekty = Молодых Ученых. Promising Innovative Projects of Young Scientists. Materials of the VII All-Russian Conference of Students, Postgraduates and Young Scientists. Nalchik Publ., 2017. P. 171-174 (In Russ.).
  3. Miziyev I.A., Makhov M.Kh. Cystatin C in The Early Diagnosis of Acute Renal Failure in Patients with Concomitant Injury. Vestnik Rossiyskoy Akademii Estestvennykh Nauk = Bulletin of the Russian Academy of Natural Sciences. 2018;1:51-55 (In Russ.).
  4. Nita M., Grzybowski A. The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxid. Med. Cell. Longev. 2016;2016:3164734. doi:10.1155/2016/3164734.
  5. Ung L., Pattamatta U., Carnt N., Wilkinson-Berka J.L., Geraldiew G., Whiteet A.J.R. Oxidative Stress and Reactive Oxygen Species: a Review of Their Role in Ocular Disease. Clinical Sci. 2017;131;4:2865-2883. doi: 10.1042/CS20171246.
  6. Yadav U.C., Kalariya N.M., Ramana K.V. Emerging Role of Antioxidants in the Protection of Uveitis Complications. Curr. Med. Chem. 2011;18;6:931-942. doi: 10.2174/092986711794927694.
  7. Rajendran N.K., George B.P., Chandran R., Tynga I.M., Houreld N., Abrahamse H. The Influence of Light on Reactive Oxygen Species and NF-кB in Disease Progression. Antioxidants (Basel). 2019;8;640:1-16. doi: 10.3390/antiox8120640.
  8. Chatterjee S. Oxidative Stress, Inflammation, and Disease Ch. 2. Oxidative Stress and Biomaterials. Ed. Dziubla T., Butterfield D.A. London, 2016. P. 35-58. doi: 10.1016/b978-0-12-803269-5.00002-4.
  9. Pavarino E.C., et al. Glutathione: Biosynthesis and Mechanism of Action. Ch. 1. Glutathione. Biochemistry, Mechanisms of Action and Biotechnological Implications. Ed. Labrou N., Flemetakis E. New York, 2013. P. 1-34.
  10. Zenkov N.K., Kolpakov A.R., Menshchikova E.B. Keap1/Nrf2/Are Redox-Sensitive System as a Phagmacological Target in Cardiovascular Diseases. Sibirskiy Nauchnyy Meditsinskiy Zhurnal = Siberian Scientific Medical Journal. 2015;35;5:5-25 (In Russ.).
  11. Bachhawat A.K., Yadav S. The Glutathione Cycle: Glutathione Metabolism Beyond the γ-Glutamyl Cycle. IUBMB Life. 2018;70;7:585-592. doi: 10.1002/iub.1756.
  12. Rushworth G.F., Megson I.L. Existing and Potential Therapeutic Uses for N-Acetylcysteine: the Need for Conversion to Intracellular Glutathione for Antioxidant Benefits. Pharmacol Ther. 2014;141;2:150-159. doi: 10.1016/j.pharmthera.2013.09.006.
  13. Samuni Y., Goldstein S., Dean O.M., Berk M. The Chemistry and Biological Activities of N-Acetylcysteine. Biochim Biophys Acta. 2013;1830;8:4117-4129. doi: 10.1016/j. bbagen.2013.04.016.
  14. Atkuri K.R., Mantovani J.J., Herzenberg L.A., Herzenberg L.A. N-Acetylcysteine – a Safe Antidote for Cysteine/Glutathione Deficiency. Curr. Opin. Pharmacol. 2007;7;4:355-339. doi: 10.1016/j.coph.2007.04.005.
  15. Wu F., Fang Y.-Z., Yang S., Lupton J. Glutathione Metabolism and Its Implications for Health. J. Nutr. 2004;134;4:489-492. doi: 10.1093/jn/134.3.489.
  16. Cacciatore I., Cornacchia C., Pinnen F., Mollica A., Di Stefano A. Prodrug Approach for Increasing Cellular Glutathione Levels. Molecules. 2010;15;3:1242-1264. doi: 10.3390/molecules15031242.
  17. Raghu G., Berk M., Campochiaro P.A., Jaeschke H., Marenzi G., Richeldi L., Wen F.-Q., Nicoletti F., Calverley P.M.A. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr. Neuropharmacol. 2021;19;8:1202-1224. doi: 10.2174/1570159X19 666201230144109.
  18. Tenório M.C.D.S., Graciliano N.G., Moura F.A., de Oliveira A.C.M., Goulart M.O.F. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel). 2021;10;6:967. doi: 10.3390/antiox10060967.
  19. Radtke K.K., Coles L.D., Mishra U., Orchard P.J., Holmay M., Cloyd J.C. Interaction of N-Acetylcysteine and Cysteine in Human Plasma. J. Pharm. Sci. 2012;101;12:4653-4659. doi: 10.1002/jps.23325.
  20. Zhou J., Coles L.D., Kartha R.V., Nash N., Mishra U., Lund T.C., Cloyd J.C. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status. J. Pharm Sci. 2015;104;8:2619-2626. doi: 10.1002/jps.24482.
  21. Shi Z., Puyo C.A. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Ther Clin. Risk Manag. 2020;16:1047-1055. doi: 10.2147/ TCRM.S273700.
  22. Mashkovskiy M.D. Lekarstvennyye Sredstva = Medicines. Moscow, Novaya volna Publ., 2020. 1216 p. (In Russ.).
  23. Akca T., Canbaz H., Tataroglu C., Caglikulekci M., Tamer L., Colak T., Kanik A., Bilgin O., Aydin S. The Effect of N-Acetylcysteine on Pulmonary Lipid Peroxidation and Tissue Damage. J. Surg. Res. 2005;129;1:38-45. doi: 10.1016/j. jss.2005.05.026.
  24. Aldini G., Altomare A., Baron G., Vistoli G., Carini M., Borsani L., Sergio F. N-Acetylcysteine as an Antioxidant and Disulphide Breaking Agent: the Reasons Why. Free Radic. Res. 2018;52;7:751-762. doi: 10.1080/10715762.2018.1468564.
  25. Jiao Y., Ma S., Wang Y., Li J., Shan L., Liu Q., Liu Y., Song Q., Yu F., Yu H., Liu H., Huang L., Chen J. N-Acetyl Cysteine Depletes Reactive Oxygen Species and Prevents Dental Monomer-Induced Intrinsic Mitochondrial Apoptosis in Vitro in Human Dental Pulp Cells. PLoS One. 2011;11;1:e0147858. doi: 10.1371/journal.pone.0147858.
  26. Szeto H.H. Mitochondria-Targeted Peptide Antioxidants: Novel Neuroprotective Agents. AAPS J. 2006;8;3:E521-E531. doi: 10.1208/ aapsj080362.
  27. Go Y.M., Chandler J.D., Jones D.P. The Cysteine Proteome. Free Radic. Biol. Med. 2015;84:227-245. doi: 10.1016/j.freeradbiomed.2015.03.022.
  28. Wardyn, J.D., Ponsford A.H., Sanderson C.M. Dissecting Molecular Cross-Talk between Nrf2 and NF-κB Response Pathways. Biochem. Soc. Trans. 2015;43;4:621-626. doi: 10.1042/BST20150014.
  29. Pasini A.M.F., Stranieri C., Cominacini L., Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel). 2021;10;2:272. doi: 10.3390/antiox10020272.
  30. Saddadi F., Alatab S., Pasha F., Ganji M.R., Soleimanian T. The Effect of Treatment with N-Acetylcysteine on the Serum Levels of C-Reactive Protein and Interleukin-6 in Patients on Hemodialysis. Saudi J. Kidney Dis. Transpl. 2014;25;1:66-72. doi: 10.4103/1319-2442.124489.
  31. Ibrahim H., Perl A., Smith D., Lewis T., Kon Z., Goldenberg R., Yarta K., Staniloae C., Williams M. Therapeutic Blockade of Inflammation in Severe COVID-19 Infection with Intravenous N-Acetylcysteine. Clin. Immunol. 2020;219:108544. doi: 10.1016/j.clim.2020.108544.
  32. AlMatar M., Batool T., Makky E.A. Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects. Curr. Drug. Metab. 2016;17;2:156-167. doi: 10.2174/1389200217666151210124713.
  33. Pei Y., Liu H., Yang Y., Yang Y., Jiao Y., Tay F.R., Chen J. Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects. Oxid. Med. Cell. Longev. 2018;2018:2835787. doi: 10.1155/2018/2835787.
  34. Nascimento M.M., Suliman M.E., Silva M., Chinaglia T., Marchioro J., Hayashi S.Y., Riella M.C., Lindholm B., Anderstam B. Effect of Oral N-Acetylcysteine Treatment on Plasma Inflammatory and Oxidative Stress Markers in Peritoneal Dialysis Patients: a Placebo-Controlled Study. Perit. Dial. Int. 2010;30;3:336-342. doi: 10.3747/pdi.2009.00073.
  35. Decramer M., Rutten-van Mzlken M., Dekhuijzen P.N.R., et al. Effects of N-Acetylcysteine on Outcomes in Chronic Obstructive Pulmonary Disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a Randomized Placebo-Controlled Trial. Lancet. 2005;365:.1552–1560.
  36. Demedts M., Behr J., et al. High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis. N. Eng. J. Med. 2005;353:2229–2242.
  37. Feldman L., Efrati S., et al. Gentamicin-Induced Ototoxicity in Hemodialysis Patients is Ameliorated by N-Acetylcysteine. Kidney Int. 2007;72;3:359-363.
  38. Fiorentini С., Falzano L., Rivabene R., Fabbri A., Malorni W. N-Acetylcysteine Protects Epithelial Cells Against the Oxidative Imbalance Due со Clostridium Difficile Toxins. FEBS Lett. 1999;453;1–2:124–128.
  39. Grandijean E.M., Berthet P., et al. Efficasy of Oral Long-Term N-Acetylcysteine in Chronic Bronchopulmonary Disease: a Meta-Analysis of Published Duble-Blind, Placebo Controlled Clinical Trials. Clin. Ther. 2000;22:209–221.
  40. Regueira F.M., Hernández J.L., Sola I., Cienfuegos J.A., Pardo F., Díez-Caballero A., Sierra A., Nwose E., Espí A., Baixaúli J., Rotellar F. Ischemic Damage Prevention by Acetylcysteine Treatment of the Donor before Orthotopic Liver Transplant. Transplantation Proceedings. 1997;29:3347–3349.
  41. Stey C., Steurer J., Bachmann S., Medici T.C., Tramèr M.R. The Effect of Oral N-Acetylcysteine in Chronic Bronchitis: a Quantitative Systematic Review. Eur. Respir. J. 2000;16:253.
  42. Van Zandwijk N., Dalesio О., Pastorino U., et al. EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients with Head and Neck Cancer or Lung Cancer. J. Natl. Cancer Inst. 2000;92:977–986.
  43. Zheng С.Н., Ahmed К., Rikicomi N., Marrinez G., Nagaiake T. The Effects of S-Carboxymethylcysteine and N-Acetylcysteine on the Adherence of Moraxella Catarrhalis to Human Pharyngeal Epithelial Cells. Microbiol. Immunol. 1999;43;2:107–113.
  44. Pavlov V.N., Pushkarev A.M., Kondratenko Ya.V., Safiullin R.I., Alekseyev A.V. Markers of Kidney Damage and Nephroprotective Therapy in Radical Cystectomy. Urologiya = Urology. 2015;5:27-30 (In Russ.).
  45. Schwalfenberg G.K. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). J. Nutr. Metab. 2021;2021:9949453. doi: 10.1155/2021/9949453.

 

The material was received 02.03.23; the article after peer review procedure 26.04.23; the Editorial Board accepted the article for publication 23.06.23
Copyright © 2024 “Disaster Medicine” Journal | Powered by “Disaster Medicine” Journal